Phyx44 develops cell-derived alternatives to conventional dairy products.
Founded in 2021 by Bharath Bakaraju, Phyx44 develops dairy alternatives using cow genes and microorganisms. Its products are designed to retain the taste and nutritional properties of conventional dairy while avoiding traditional dairy farming. The company is based in Bangalore, India, with operations in Singapore. In November 2022, it raised USD 1.2 million in seed funding led by Better Bite Ventures, with participation from Ahimsa VC, PeerCapital, Spectrum Impact, Big Idea Ventures and Humane Society International.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in